CUSIP: 28249H104
Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,808,886
-
Share change
-
-493,370
-
Total reported value
-
$304,796,949
-
Price per share
-
$31.08
-
Number of holders
-
76
-
Value change
-
-$14,549,458
-
Number of buys
-
37
-
Number of sells
-
28
Quarterly Holders Quick Answers
What is CUSIP 28249H104?
CUSIP 28249H104 identifies EIDX - EIDOS THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2019
-
Previous quarter:
Q1 2019
Recent filing periods for CUSIP 28249H104:
Institutional Holders of EIDOS THERAPEUTICS INC - COM (EIDX) as of Q2 2019
As of 30 Jun 2019,
EIDOS THERAPEUTICS INC - COM (EIDX) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,808,886 shares.
The largest 10 holders included
BlackRock Inc., Aisling Capital Management LP, Viking Global Investors LP, Redmile Group, LLC, PERCEPTIVE ADVISORS LLC, LORD, ABBETT & CO. LLC, Cormorant Asset Management, LP, VANGUARD GROUP INC, Candriam Luxembourg S.C.A., and Opaleye Management Inc..
This page lists
76
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.